Delivery Order SPE2DR25D2205-SPE2DR26F2B30
Award Date 2/11/26
Potential Completion Date 3/5/26
Potential Value $8.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for HYPERRAB 300 Unit/ML Vial pharmaceutical product, with a ceiling value of $9,475.20. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. The order is priced firm fixed price with no set-aside applied. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. and holds a significant Indefinite Delivery Contract with DLA Troop Support Medical...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for $3,158.40 (firm fixed price) under the DLA Troop Support Medical indefinite delivery contract for HYPERRAB 300 unit/ml vial pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for HYPERRAB 300 Unit/mL Vial 5mL at a ceiling value of $10,686.55 under a firm fixed price contract. This delivery order represents a non-competitive, competitively awarded procurement with an ultimate completion date of September 24, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials (5mL) with a ceiling value of $17,337.40 under a firm fixed price contract type. The award was made on November 20, 2025, with an ultimate completion date of December 12, 2025. This delivery order is non-set-aside and competitively awarded, reflecting AmerisourceBergen's capability to meet federal procurement requirements. The place of performance is the company's corporate...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, for hyperimmune rabies immunoglobulin (HYPERRAB 300 UNIT/ML, 5ML vials) with a ceiling value of $27,509.16. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 2, 2026. The delivery order was issued under the DLA Troop Support Medical IDC, a single-award indefinite delivery contract valued at up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of HYPERRAB 300 Unit/ML vial in 5ML quantities, with a ceiling value of $8,668.70 and a completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $1,790.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML vial (5ML) on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside contract, competitively awarded to support federal medical procurement needs. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of HYPERRAB 300 Unit/ML Vials, with a ceiling value of $4,158.12 and an ultimate completion date of November 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a $8,668.70 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vial 5mL on December 12, 2025, with an ultimate completion date of January 6, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- <p>The Defense Logistics Agency issued a $1,649.10 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for HYPERRAB 300 Unit/ML Vial 5ML, with an ultimate completion date of February 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.</p>